pubmed-article:18268280 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0017296 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0025936 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0005283 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C1158478 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C1705422 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:18268280 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:18268280 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:18268280 | pubmed:dateCreated | 2008-3-3 | lld:pubmed |
pubmed-article:18268280 | pubmed:abstractText | beta-thalassemia is one of the most common genetic diseases in the world and requires extensive therapy. Lentiviral-mediated gene therapy has been successfully exploited in the treatment of beta-thalassemia and showed promise in clinical application. Using a human beta-globin transgenic mouse line in a beta-thalassemia diseased model generated with a lentiviral-mediated approach, we investigate the stable therapeutic effect on a common thalassemia syndrome. | lld:pubmed |
pubmed-article:18268280 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18268280 | pubmed:language | eng | lld:pubmed |
pubmed-article:18268280 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18268280 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18268280 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18268280 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18268280 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18268280 | pubmed:month | Mar | lld:pubmed |
pubmed-article:18268280 | pubmed:issn | 1592-8721 | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:GálE MEM | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:FuY PYP | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:WangShuS | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:HuangShuzhenS | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:ZengFanyiF | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:ZengYitaoY | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:RenZhaoruiZ | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:XieShuyangS | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:GuoXinbingX | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:GongXiuliX | lld:pubmed |
pubmed-article:18268280 | pubmed:author | pubmed-author:ZhangJingzhiJ | lld:pubmed |
pubmed-article:18268280 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18268280 | pubmed:volume | 93 | lld:pubmed |
pubmed-article:18268280 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18268280 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18268280 | pubmed:pagination | 356-62 | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:meshHeading | pubmed-meshheading:18268280... | lld:pubmed |
pubmed-article:18268280 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18268280 | pubmed:articleTitle | A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy. | lld:pubmed |
pubmed-article:18268280 | pubmed:affiliation | Shanghai Institute of Medical Genetics, Shanghai Children's Hospital, Shanghai Jiaotong University School of Medicine, 1400/24 West Beijing Road, Shanghai, China. | lld:pubmed |
pubmed-article:18268280 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18268280 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18268280 | lld:pubmed |